Regulatory · source year

2008 regulatory records

10 selected, source-linked regulatory records dated 2008. This is selective source coverage, not a complete timeline.

Dated records

10 selected records.

Peptide profiles

6 connected profiles.

Cited sources

10 distinct public records.

Cited chronology

Dated source records

All record types in 2008 →

December 2008

1 record

November 2008

2 records

Lanreotide

Federal Register notice E8-27179

The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.

Source: Federal Register via GovInfo ↗

→

October 2008

2 records

Octreotide

Federal Register notice E8-24356

The Federal Register published notice E8-24356, attributed to FDA and its parent HHS department, on 2008-10-15. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Source: Federal Register via GovInfo ↗

→

Desmopressin

Federal Register rule E8-24050

The Federal Register published rule E8-24050, attributed to FDA and its parent HHS department, on 2008-10-09. Its official title is “Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive Hemophilia Diagnostic Treatment Centers That Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

May 2008

1 record

March 2008

3 records

January 2008

1 record